Innovation Hub

The latest breakthroughs, technologies, and resources organized across every stage in the drug development lifecycle.

Featured

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Developing a Clinical Outcome Assessment (COA) strategy too late can compromise endpoints, delay timelines, and devalue study evidence. Join these experts to explore practical strategies for early COA planning, instrument selection, global linguistic validation, and meeting regulatory evidence expectations before locking your endpoints.

Highlight

Blog

What to Know About AAV Quality Before the Experiment Begins

Blog

In Vivo Study: From Study Design, Execution to Pathology Assessment in One Laboratory at APS

Upcoming Webinars

From the Blog

Browse by Stage

Discovery & Preclinical

Supporting early-stage research with the tools and expertise to move from hypothesis to candidate.

+ More

Clinical

Resources spanning Phase I–III, from trial design to patient recruitment and data management.

Biometrics

Clinical Trials

Trial Insights

+ More

Pharmaceutical Development & Manufacturing

Insights across formulation, scale-up, and GMP manufacturing.

Chemical & Compound Analysis

Discovery Chemistry

+ More

Medical & Commercial

Guidance on market access, medical affairs, and commercialization strategy.

Medical Communications

Discovery Chemistry

+ More

Podcasts

Podcast

ShareSci

#ShareScience is a podcast by InsideScientific, the online environment for Life Science webinars, virtual events, interviews and educational content that helps you do your best work.

Podcast

tHEORetically Speaking

Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care.

Podcast

#ExpertAnswers

#ExpertAnswers is a podcast by InsideScientific, the online environment for Life Science webinars, virtual events, interviews and educational content that helps you do your best work.

Innovation Hub

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Heading

What to Know About AAV Quality Before the Experiment Begins

In Vivo Study: From Study Design, Execution to Pathology Assessment in One Laboratory at APS

Heading

Beyond Ejection Fraction: Hemodynamic Force Analysis in a Murine Pressure Overload Model Using Vevo Strain 2.0

Beyond Affinity: Multi-Parameter Optimization of Multispecific Building Blocks

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Smarter Drug Discovery: Turning Screening Hits into Opportunities

Improving Translational Decision-Making through Disease-Relevant Preclinical Models in Pulmonary Fibrosis and Pain Drug Discovery

Advancing Metabolic Disease Drug Development: Translational Models and a GLP-1 Receptor Agonist Metabolism Case Study

Upcoming Webinars

The latest from the Innovation Hub, straight to your inbox.

What AI Finds in Clinical Notes About Myasthenia Gravis That Claims Data Misses

In Vivo Study: From Study Design, Execution to Pathology Assessment in One Laboratory at APS

What to Know About AAV Quality Before the Experiment Begins

Immortalized vs. Primary Cells: Choosing the Right Model for Your Research

Connecting Discovery: How Integrated Infrastructure Supports Better Decisions

What Experimental Data Do AI-Designed Antibodies Need?

The Evolving Landscape of Drug Discovery for Metabolic Diseases

June 2026 Medical/Commercial Pulse Check

Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery

Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery

Reducing risk in CRO studies: Choosing the right cell models for outsourced research

Cutting Months Off AAV Programs: The Synthetic DNA Shift

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Industry Insights: Behind the Scenes of BPS Bioscience Custom R&D

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Advanced Screening Strategies for Molecular Glue Discovery

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Supplier Spotlight: RadMD Imaging

AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.

The Science of the "Gut Feeling": Why Techs are a Lab's Best Diagnostic Tool

Supplier Spotlight: MedChemExpress

HealthEconomics.com 2026 Pulse Check – March

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

2026 PharmDev Roadmap: The Regulatory Shift

Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models

From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters

2026 PharmDev Roadmap: The Strategic Partner

2026 PharmDev Roadmap: The Predictive Model

2026 PharmDev Roadmap: The Complexity Spike

Explore FUJIFILM's Cyclic Peptide Discovery Service

From the Blog

Browse by Stage

Discovery & Preclinical

Clinical

Pharmaceutical Development & Manufacturing

Medical & Commercial

Podcasts

ShareSci

tHEORetically Speaking

#ExpertAnswers

INsights & OUTcomes with Renée Arnold

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap

Talking Real Science with Stella Goulopoulou

Talking Real Science with Yelena Akelina

#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments

Talking Real Science with Licy Yanes Cardozo

Industry Insights with Bas Trietsch and STEMCELL Technologies

Talking Real Science with Helen Collins

Talking Real Science with Rachel Buckley

Talking Real Science with Meaghan Loy on Rare Disease Day

Other podcasts

The Digital Backbone for Modern Life Sciences